| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e2f4a0d225fc8cb661b2829583bbf8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_462b81735ce59e5e0b4da654d27aa0ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_437b6edb7bee184008dba139732e3d82 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10371
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2474
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2010-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaa146824c9bcfa8e77728059ebc84ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91f8a96bace84a327f3836874382ea8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_576ac39171ffda7a0dbc45074cd14a67 |
| publicationDate |
2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012148535-A1 |
| titleOfInvention |
Oncolytic adenoviruses for treating cancer |
| abstract |
The invention is related to an oncolytic adenovirus that comprises a sequence encoding a hyaluronidase enzyme inserted in its genome. This adenovirus spreads more efficiently in the tumour mass and therefore the oncolytic effect is increased. Injecting the oncolytic adenovirus of the invention endovenously, tumour volume regressions are obtained. Therefore the oncolytic adenovirus of the present invention is useful for the treatment of a cancer or a pre-malignant state of cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114703186-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578104-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000560-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016061286-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11414489-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022347244-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9677061-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016178167-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9969998-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016033555-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10604549-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11584923-B2 |
| priorityDate |
2009-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |